0001225208-11-027054.txt : 20111229
0001225208-11-027054.hdr.sgml : 20111229
20111229123130
ACCESSION NUMBER: 0001225208-11-027054
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20100306
FILED AS OF DATE: 20111229
DATE AS OF CHANGE: 20111229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Caldarella Joseph C
CENTRAL INDEX KEY: 0001341069
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 111285759
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: RT 206 & PROVINCELINE ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4/A
1
doc4a.xml
X0304
4/A
2010-03-06
2010-03-09
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001341069
Caldarella Joseph C
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
VP & Financial Controller
Restricted Stock Units
0.0000
2010-03-06
4
M
0
1412.0000
0.0000
D
2008-03-06
Common Stock, $0.10 par value
1412.0000
1412.0000
D
Each restricted stock unit converts into one share of common stock upon vesting.
Twenty-five percent of the restricted stock units will vest on each of the first, second, third and fourth anniversaries of the grant date and be converted into shares of common stock.
This Form 4 is being amended to reflect the correct number of derivative securities beneficially owned following this reported transaction. The number of derivative securities beneficially owned following the transaction reported for this award in a Form 4 filed on March 8, 2011 was also reported incorrectly.
Exhibit 24 - Power of Attorney
/s/ Robert J. Wollin, attorney-in-fact for Joseph C. Caldarella
2011-12-29
EX-24
2
caldarella_poa.txt
Exhibit 24
POWER OF ATTORNEY
I, Joseph C. Caldarella, Senior Vice President and Controller of
Bristol-Myers Squibb Company (the "Company"), a corporation duly organized
and existing under the laws of the State of Delaware, in the United States
of America, and having its principal place of business at 345 Park Avenue,
New York, New York, do hereby constitute and appoint each of Sandra Leung,
Katherine R. Kelly, and Robert J. Wollin, individually, as my lawful
attorney-in-fact and in my name, place and stead to execute and deliver any
and all documents relating to insider reporting requirements under Section 16
of the Securities Exchange Act of 1934, with respect to securities issued by
the Company, including, without limitation, the execution and filing of all
Forms 3, 4 and 5, and to take such other action, as such attorney considers
necessary or appropriate, to effectuate such transactions. This Power of
Attorney shall remain in full force and effect until I am no longer required
to file Forms 3, 4, and 5 with respect to securities issued by the Company,
unless earlier revoked.
IN WITNESS WHEREOF, I have executed this Power of Attorney on this
20th day of September, 2011.
/s/ Joseph C. Caldarella
Joseph C. Caldarella